Mattia Prosperi, Ph.D., named PHHP associate dean for AI and innovation
Mattia Prosperi, Ph.D., a Cancer Center member, was appointed to a leadership role in AI in the College of Public Health & Health Professions.
All Posts by
Mattia Prosperi, Ph.D., a Cancer Center member, was appointed to a leadership role in AI in the College of Public Health & Health Professions.
With a $2.3 million grant, the team will investigate strategies to treat muscle wasting and weakness caused by pancreatic cancer.
The team discovered similarities in how two human herpesviruses and a mouse herpesvirus create genetic changes that can cause cancer.
UF College of Pharmacy researchers identified two small molecules that inhibit precancerous cell progression in pancreatic cancer.
A team of UF researchers has shed new light on the functional mechanisms of spontaneous calcium waves in human colon and prostate cancer cells.
A team of UF researchers has shed new light on the functional mechanisms of spontaneous calcium waves in human colon and prostate cancer cells.
The findings could pave the way for developing new drug targets to overcome treatment resistance.
A team used genome-wide CRISPR/cas9 screening to identify genes that are sensitive or resistant to etoposide, which is used to treat pediatric AML.
A research team led by Elias Sayour, M.D., Ph.D., has received funding from the UF McKnight Brain Institute for a brain cancer project.
The campaign features technology and resources to improve knowledge and increase screening for people with higher-than-average risk for breast cancer.